Interestingly, preventive and therapeutic vaccination with a fusion protein of C5a and maltose-binding protein induced C5a-neutralizing antibodies, which significantly reduced the incidence and severity of joint inflammation in three models of experimental arthritis [53]. This evidence concerns the gene C5AR1 and arthritic joint disease.